NCT02377713View on ClinicalTrials.gov

A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Alzheimer's Disease
Interventions
DRUG

KHK6640

Single ascending dose administration

DRUG

Placebo

Single ascending dose administration

Trial Locations (1)

Unknown

Tokyo

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT02377713 - A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease. | Biotech Hunter | Biotech Hunter